Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer. Prager GW, Taieb J, Fakih M, Ciardiello F, et al. N Engl J Med 2023;388:1657-1667.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Prager GW, Taieb J, Fakih M, Ciardiello F, et al. Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer. N Engl J Med 2023;388:1657-1667.
PMID: 37133585